Free Trial
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

Carl Zeiss Meditec logo
€54.85 -2.05 (-3.60%)
As of 06/2/2025

About Carl Zeiss Meditec Stock (ETR:AFX)

Key Stats

Today's Range
€54.20
€56.30
50-Day Range
€48.74
€65.90
52-Week Range
€54.60
€123.75
Volume
209,811 shs
Average Volume
94,405 shs
Market Capitalization
$5.11 billion
P/E Ratio
29.31
Dividend Yield
2.01%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
J.P. Morgan Sticks to Their Sell Rating for Carl Zeiss Meditec (0DHC)
See More Headlines

AFX Stock Analysis - Frequently Asked Questions

Carl Zeiss Meditec's stock was trading at €45.52 at the start of the year. Since then, AFX shares have increased by 20.5% and is now trading at €54.85.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
ETR:AFX
CIK
N/A
Fax
N/A
Employees
4,950
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.31
Forward P/E Ratio
18.78
P/E Growth
2.83
Net Income
$185.59 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.64 billion
Cash Flow
€0.04 per share
Price / Cash Flow
1,398.28
Book Value
€22.92 per share
Price / Book
2.39

Miscellaneous

Free Float
N/A
Market Cap
$5.11 billion
Optionable
Not Optionable
Beta
0.98
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ETR:AFX) was last updated on 6/3/2025 by MarketBeat.com Staff
From Our Partners